Showing results (51-60 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|January 19, 2019
Is P2Y12 inhibitor therapy associated with an increased risk of cancer?Christoph C Kaufmann, Alexander R Lyon, Johann Wojta, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 1, 2018
Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare systemTodd C Villines, Azhar Ahmad, Michaela Petrini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2019
Impact of vitamin D on cardiac structure and function in chronic kidney disease patients with hypovitaminosis D: a randomized controlled trial and meta-analysisDebasish Banerjee, Nihil Chitalia, Irina Chis Ster, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2020
Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary interventionSeung Hun Lee, Hyun Kuk Kim, Myung Ho Jeong, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 17, 2020
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSYFelice Gragnano, Dik Heg, Anna Franzone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 28, 2020
Off-label use of reduced dose direct oral factor Xa inhibitors in subjects with atrial fibrillation: a review of clinical evidenceMario Bo, Alberto Corsini, Enrico Brunetti, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2022
Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular diseaseGerasimos Filippatos, Stefan D Anker, Bertram Pitt, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 5, 2025
The role of cangrelor in acute and high-risk PCI settingsUwe Zeymer, Tobias Geisler, Dirk Westermann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 14, 2025
Sex-Related Variations in Platelet Reactivity in Presence or Absence of Antiplatelet TherapyMattia Galli, Sergio Terracina, Eleonora Schiera, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 2, 2025
Chronic Coronary Syndrome and New-Onset Atrial Fibrillation or Venous Thromboembolism: How Best to Manage Antithrombotic Therapy StrategiesAndrea Rubboli, Dominick J Angiolillo, Cecilia Becattini, et al.
Pageof 53